Spin-Off

As Embecta prepares its Q1 results, investors watch closely to see if its move beyond insulin can reverse recent revenue declines and reshape its future.

A new documentary unearths the untold story of 600,000 Black 'Rosie the Riveters' who battled racism and sexism to help win World War II.

Semiconductor leader Qnity sees CFO Matt Harbaugh depart for health reasons, but reaffirms strong 2025 guidance, signaling stability to the market.

In under five months, Weitz's new bond ETF hit a key milestone, signaling a major shift as advisors embrace active management in the ETF wrapper.

AI automation leader Esker brings on a seasoned CFO with a history of IPOs and tech transformations, signaling a new phase of aggressive global expansion.

As SKF readies its Q4 2025 report, all eyes are on its performance as a bellwether for global industry and a verdict on its major strategic overhaul.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

With promising data in hard-to-treat cancers, iOnctura's lead drug, roginolisib, is set to make waves at the top healthcare investment forum.

A new pact between AUMOVIO and AWS leverages generative AI to slash AV development time, with driverless trucks for Aurora first in line.

WK Kellogg Co is betting big on its first Super Bowl ad for Raisin Bran, using a mystery celebrity to spotlight a national health issue. Will it work?

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

Investors await Polaris's Q4 results on Jan. 27, seeking clarity on market share gains, tariff impacts, and the future of its Indian Motorcycle brand.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

A new partnership between power module expert SOLUM and charger innovator i-charging aims to supercharge e-mobility with next-gen tech and a human-centric vision.

As LunR Royalties begins trading, its parent NGEx Minerals pivots to unlock the potential of its world-class copper-gold assets in South America.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.

Following a major legal victory in Peru, American Lithium will spin out its massive Macusani uranium project to capitalize on a surging nuclear energy market.

GrantWatch founder Libby Hikind is trading grant databases for picture books. Discover the strategy behind her pivot to value-driven children's literature.

Nasdaq-listed Society Pass is ditching its e-commerce roots for the AI gold rush. Is this a savvy M&A masterstroke or a risky gamble in a capital-heavy arena?